MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31

MESA LABORATORIES INC /CO/

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$123.31+0.83 (+0.67%)

Close on Oct 19, 2026

Market cap: $709.87M
P/E (TTM): 145.1
Dividend yield: 0.52%

MESA LABORATORIES INC /CO/ income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31	FY 2016 2016-03-31	FY 2015 2015-03-31	FY 2014 2014-03-31	FY 2013 2013-03-31	FY 2012 2012-03-31	FY 2011 2011-03-31
Revenue	249	241	216	219	184	134	118	103	96	94	85	71	53	46	40	34
Cost of Revenue	91	90	83	85	75	47	52	42	42	40	33	28	21	18	16	15
Gross Profit	158	151	133	134	109	87	65	61	55	53	51	43	32	29	24	20
Research & Development	20	20	19	20	16	10	6.36	3.51	3.54	4.16	3.97	3.29	2.32	2.01	1.36	1.44
Selling, General & Admin	–	–	–	–	–	–	–	–	–	–	–	–	–	–	9.33	8.26
Selling & Marketing	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.91	3.69
General & Administrative	79	73	73	72	60	46	38	31	26	23	24	17	11	9.12	5.42	4.58
Operating Expenses	140	135	405	130	104	75	57	51	52	37	35	28	20	16	11	9.70
Operating Income	19	16	-272	3.32	4.70	12	7.92	9.78	2.18	16	16	16	12	13	12	9.86
Interest Expense	11	12	5.70	4.77	3.89	8.02	5.50	1.75	1.85	–	–	–	–	–	–	–
Interest & Investment Income	–	–	–	–	–	0.11	0.96	0.03	0.01	–	–	–	–	–	–	–
Other Non-Operating Income	-6.50	-10	-3.57	-3.71	-1.13	-10	-4.06	-1.16	-1.88	-2.02	-0.77	-0.52	1.32	-0.13	-0.15	-0.11
Asset Impairment Charges	0	0	275	0	0	0	0.30	4.77	14	–	–	–	–	–	0.35	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	-0.03	0.29	0.12	–	–	-0.02	0.42	–	–	–
Legal Settlements	–	–	–	–	–	-0.09	-0.05	-3.30	–	–	–	–	–	–	–	–
Pretax Income	12	5.96	-276	-0.39	3.57	2.30	3.86	8.62	0.30	14	16	15	13	13	12	9.75
Income Tax Expense	5.30	7.94	-21	-1.32	1.70	-0.97	2.08	1.14	3.26	3.11	4.39	5.76	4.10	4.53	4.41	3.57
Income from Continuing Operations	12	5.96	-276	-0.39	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	6.71	-1.97	-254	0.93	1.87	3.27	–	–	–	–	–	–	–	–	–	–
Net Income to Common	6.71	-1.97	-254	0.93	1.87	3.27	1.78	7.48	-2.96	11	11	9.58	9.00	8.45	7.92	6.18
EPS (Basic)(per share)	1.22	-0.36	-47.20	0.17	0.36	0.66	0.42	1.95	-0.79	3.04	3.10	2.72	2.61	2.52	2.41	1.91
EPS (Diluted)(per share)	1.21	-0.36	-47.20	0.17	0.35	0.64	0.41	1.86	-0.79	2.91	2.97	2.63	2.49	2.35	2.29	1.86
Shares Outstanding (Basic, Weighted)(shares)	5.51	5.42	5.39	5.32	5.21	4.98	4.20	3.84	3.77	3.68	3.61	3.52	3.45	3.36	3.29	3.23
Shares Outstanding (Diluted, Weighted)(shares)	5.57	5.42	5.39	5.36	5.34	5.12	4.37	4.03	3.77	3.84	3.76	3.65	3.61	3.59	3.46	3.33
Dividend per Share(per share)	0.64	0.64	0.64	0.64	0.64	0.64	0.64	0.64	–	–	–	–	–	–	–	–
EBITDA	–	–	–	37	30	30	21	19	12	25	23	22	16	17	15	12

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 64.2%
Operating margin: 9.0%
Net margin: 1.9%
Return on equity, FY2026: 3.9%

Financial strength

Current ratio: 1.79
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 53.5%

Valuation

P/E ratio: 145.1
Price to sales: 2.84
Price to book: 3.76
Dividend yield: 0.52%